Table 4 Prevalence of metabolic dysregulations in patients with schizophrenia
From: Prevalence of metabolic syndrome among patients with Schizophrenia in Palestine
MS ATP-III A | All Frequency (%) | Male | Female | OR (95% CI) and d (Cohen’s value) | P | Chi-Square value |
|---|---|---|---|---|---|---|
WC (M > 102 cm; F > 88 cm) | 114 (45.6%) | 58 (31.9%) | 56 (82.4%) | 0.1 (0.05 – 0.2) d = −1.3 | <0.01 | 50.9 |
FPG (≥100 mg/dL) | 80 (32%) | 52 (28.6%) | 28 (41.2%) | 0.6 (0.3 – 1.02) d = −0.28 | 0.06 | 3.6 |
HDL (M < 40 mg/dl; F < 50 mg/dl) | 130 (52%) | 87 (47.8%) | 43 (63.2%) | 0.53 (0.3 – 0.94) d = −0.35 | 0.03 | 4.7 |
BP (≥ 130/85 mmHg) | 129 (51.6%) | 92 (50.5%) | 31 (45.6%) | 1.2 (0.68 – 2.1) d = 0.1 | 0.55 | 0.35 |
TG (> 150 mg/dl) | 123 (49.2%) | 96 (52.7%) | 33 (48.5%) | 1.2 (0.7 – 2.1) d = 0.1 | 0.5 | 0.49 |